Your genes can impact how you respond to a GLP-1 In a study published in Genome Medicine , researchers found that about 10 percent of people carry certain variants of what's known as the PAM gene, and those individuals had a weaker blood sugar response to GLP-1based drugs compared to non-carriers
The cost difference is enormous
Our body composition analysis using the Body Composition Scans provides a detailed breakdown of your muscle mass, body fat percentage, hydration status and visceral fat levels
Canyelles, M., Borrs, C., Rotllan, N., Tondo, M., Escol-Gil, J
Jens Juul Holst, a Danish GLP-1 expert at the University of Copenhagen, later recalled Engs frustration to Science magazine in 2018: He was extremely frustrated